BioCentury
ARTICLE | Clinical News

Poniard, Verastem preclinical data

November 19, 2012 8:00 AM UTC

In a mouse xenograft model of TNBC, VS-4718 significantly reduced primary (p=0.05) and secondary (p=0.0015) cancer stem cells in tumors vs. vehicle-treated controls. In vitro, VS-4718 reduced the perc...